Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Guard Therapeutics International AB

Market Cap 31.3M 3.27M 2.85M 2.64M 2.47M 4.63M 308M 4.66M 12.13M 152M 12.26M 12M 527M P/E 2026 *
0.67x
P/E 2027 * 0.6x
Enterprise Value -84.7M -8.84M -7.71M -7.14M -6.68M -12.53M -834M -12.61M -32.83M -411M -33.19M -32.48M -1.43B EV / Sales 2026 *
-0.69x
EV / Sales 2027 * -1.14x
Free-Float
65.85%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Guard Therapeutics International AB

1 day+2.11%
1 week-2.39%
Current month+8.23%
1 month+10.86%
3 months+0.13%
6 months+19.85%
Current year+5.58%
1 week 1.35
Extreme 1.35
1.6
1 month 1.2
Extreme 1.2
2.14
Current year 0.88
Extreme 0.881
2.35
1 year 0.88
Extreme 0.881
27
3 years 0.88
Extreme 0.881
49.8
5 years 0.88
Extreme 0.881
112.5
10 years 0.88
Extreme 0.881
3,050
Manager TitleAgeSince
Chief Executive Officer 50 2019-01-14
Director of Finance/CFO 53 2020-09-13
Chief Tech/Sci/R&D Officer 66 2021-12-31
Director TitleAgeSince
Chairman 70 2021-04-30
Director/Board Member - 2024-04-30
Director/Board Member 63 2019-05-28
Date Insider Type Main position Quantity % Market Cap.
23-02-27Free

Chief Financial Officer

2,520,000 0.5009%
23-02-27Free

Executive/Senior Manager

1,680,000 0.3339%
23-02-27Free

Chief Executive Officer

9,450,000 1.8784%
Change 5-day change 1-year change 3-year change Capi.($)
+2.11%-2.39%-90.79%-76.48% 3.27M
+1.44%+1.71%-10.63%-9.16% 43.13B
+3.31%+5.93%+308.19%+562.02% 34.65B
+2.84%+2.14%+6.87%+34.93% 30.03B
-1.70%-7.54%+8.51%-22.34% 28B
-1.90%-1.56%+11.62%+19.80% 24.45B
-0.14%+5.86% - - 14.34B
+0.68%-1.53%+52.04%+107.47% 13.14B
-0.57%-2.43%+5.18%+4.20% 12.53B
-0.26%+1.15%+100.27%+80.69% 12.25B
Average +0.58%+0.74%+43.47%+77.90% 21.25B
Weighted average by Cap. +0.77%+1.27%+65.22%+113.22%

Financials

2026 *2027 *
Net sales 123M 12.84M 11.19M 10.37M 9.71M 18.2M 1.21B 18.31M 47.67M 596M 48.2M 47.16M 2.07B 123M 12.84M 11.19M 10.37M 9.71M 18.2M 1.21B 18.31M 47.67M 596M 48.2M 47.16M 2.07B
Net income 51M 5.32M 4.64M 4.3M 4.02M 7.55M 502M 7.59M 19.77M 247M 19.98M 19.56M 859M 58M 6.05M 5.28M 4.89M 4.58M 8.58M 571M 8.64M 22.48M 281M 22.73M 22.24M 976M
Net Debt -116M -12.11M -10.56M -9.78M -9.15M -17.17M -1.14B -17.27M -44.96M -562M -45.45M -44.48M -1.95B -172M -17.95M -15.65M -14.5M -13.57M -25.45M -1.69B -25.61M -66.66M -834M -67.4M -65.95M -2.9B
Logo Guard Therapeutics International AB
Guard Therapeutics International AB (publ), formerly A1M Pharma AB, is a Sweden-based company, which is active within the healthcare sector. The Company conducts development and commercialization of treatment and diagnostics based on the alpha-1-microglobulin (A1M) protein. The protein serves as a radical inhibitor, an antioxidant, a protector against free hemoglobin and a tissue repairer. A1M is a candidate for different therapeutic and diagnostic uses, such as alleviation of autoimmune diseases and stroke treatment. The Company works with the protein and conducts research at the Biomedical Center in Lund University, Sweden. The Company develops a drug for intravenous treatment of preeclampsia, a condition that can occur during pregnancy and can contribute to premature deliveries.
Employees
12
Date Price Change Volume
26-06-18 1.552 kr +2.11% 12,223
26-06-17 1.520 kr -1.94% 11,656
26-06-16 1.550 kr -2.52% 31,762
26-06-15 1.590 kr 0.00% 93,872
26-06-12 1.590 kr +3.25% 215,255

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GUARD Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!